5AM VENTURES other names

{{ Info.Overview }}
Revenue: {{ Info.Revenue | formatUSD }} Headquarters: {{ Info.Headquarters }}

Adviser Profile

As of Date:

08/15/2024

Adviser Type:

- Large advisory firm


Number of Employees:

37 5.71%

of those in investment advisory functions:

19 -9.52%


Registration:

SEC, Approved, 1/19/2021

Other registrations (3)
Former registrations

5AM VENTURES

AUM:

1,453,938,677 -15.97%

of that, discretionary:

1,453,938,677 -15.97%

Private Fund GAV:

1,453,938,677 -15.97%

Avg Account Size:

132,176,243 -15.97%


SMA’s:

NO

Private Funds:

11

Contact Info

415 xxxxxxx

Websites :
Client Types:

+

Advisory Activities:

+

Compensation Arrangments:

+

Reported AUM

Discretionary
Non-discretionary
2B 2B 1B 1B 858M 572M 286M
2020 2021 2022 2023

Recent News

Viveve Medical Inc.
04/06/2021

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Barrons

Cabaletta Bio Inc.
04/01/2021

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Barrons

Cidara Therapeutics Inc.
04/01/2021

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Barrons

scPharmaceuticals Inc.
04/01/2021

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Barrons

Crinetics Pharmaceuticals Inc.
04/01/2021

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Barrons


Private Funds Structure

Fund Type Count GAV
Private Equity Fund 2 $387,903,536
Venture Capital Fund 9 $1,066,035,141

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM # funds
IDG CAPITAL FUND MANAGEMENT LTD. - - 264.0m - - 10.1b - 20.5b - 16
POLARIS GROWTH MANAGEMENT, LLC - - 649.4m - - 3.8b - 8.3b 4.5b 15
CORNER CAPITAL MANAGEMENT, LLC - - 102.1m - - 647.7m - 1.4b 749.8m 28
JVP - - 809.7m - - 1.1b - 3.0b - 33
ALPACA - - 5.9m - - 177.8m - 361.5m 184.2m 12
INSIGNIA VENTURES PARTNERS PTE. LTD. - - 50.5m - - 1.3b - 2.6b - 6
CAMBIUM CAPITAL MANAGEMENT LP - - 8.4m - - 94.1m - 196.6m - 5
INSPIRATION VENTURE PARTNERS - - 14.0m - - 120.1m - 254.2m - 5
VILLAGE GLOBAL MANAGEMENT, L.L.C. - - 21.0m - - 530.9m - 1.1b 552.4m 5
LONGVIEW INNOVATION CORP. - - 1.1m - - 124.0m - 249.2m 125.1m 5

Private Funds



Employees




Brochure Summary

Overview

A. Description of the Advisory Firm A. 5AM Venture Management, LLC (“5AM” or the “Firm”) was founded in 2002. 5AM serves as an investment adviser to pooled investment vehicles (each, a “Fund” and collectively, the “Funds”). An affiliate of 5AM serves as the general partner of each Fund (the “General Partners”). The General Partners are registered under the Advisers Act pursuant to 5AM’s registration as an investment adviser in accordance with SEC guidance. These entities operate as a single advisory business together with 5AM and share common owners, officers, partners, employees, consultants or persons occupying similar positions. The General Partners are under common control and subject to 5AM’s code of ethics and compliance programs adopted pursuant to the requirements of the Advisers Act. The Firm’s headquarters is located in San Francisco, CA with additional offices in Boston, MA and New York, NY. 5AM’s principal owners are Andrew Schwab and Kush Parmar. They serve as the Firm’s Managing Partners. B. Types of Advisory Services 5AM offers discretionary investment advice to the Funds under two investment platforms: (1) venture funds and their related co-investment vehicles that make early-stage venture capital investments into life science companies (the “Venture Funds”) and (2) funds that make follow-on investment rounds in life science
companies in which the Venture Funds have existing interests and later stage private and publicly held companies in life science related fields (the “Opportunities Funds”) (collectively, the Venture Funds and Opportunities Funds, the “Funds”). 5AM pursues investments in advanced life science innovations, and seeks to be diversified across the biopharmaceutical therapeutics, and platform technologies. Within each sector, 5AM invests across multiple therapeutic areas and modalities on behalf of the Funds, and evaluates opportunities based on innovative platform technologies, corporate spin-offs and products with shorter development cycles. C. Client Tailored Services and Client Imposed Restrictions 5AM provides investment advisory services to each Fund in accordance with such Fund’s private placement memorandum, limited partnership agreement (“LPA”) (or analogous organizational document), separate investment advisory agreements or contractual side letters with such Fund's investors, as applicable (the “Governing Documents”). D. Wrap Fee Programs 5AM does not participate in wrap fee programs. E. Amounts Under Management As of December 31, 2023, 5AM manages approximately $1,453,938,677 in regulatory assets, including uncalled capital commitments, on a discretionary basis. The Firm does not manage any assets on a non-discretionary basis.